Literature DB >> 22080049

Elevated labile Cu is associated with oxidative pathology in Alzheimer disease.

Simon A James1, Irene Volitakis, Paul A Adlard, James A Duce, Colin L Masters, Robert A Cherny, Ashley I Bush.   

Abstract

Oxidative stress is implicated in Alzheimer disease (AD) pathogenesis, for which evidence indicates that radical species are generated by the redox-active biometal Cu. The contribution of labile Cu to the oxidative stress observed in AD has not been evaluated. The Cu content of postmortem cortical tissue from nondemented elderly controls and AD cases was measured using inductively coupled plasma mass spectroscopy, and the proportion of labile Cu was assessed using the Cu-phenanthroline assay. Further, the capacity of the tissue to stabilize Cu(2+) was evaluated using immobilized metal-affinity chromatography, and the level of tissue oxidative damage was determined by the presence of thiobarbituric acid-reactive compounds. We identified elevated levels of exchangeable Cu(2+), which were correlated with tissue oxidative damage; additionally, we noted an increased capacity of AD cortical tissue samples to bind Cu(2+). This deranged Cu homeostasis reflects the homeostatic breakdown of Cu observed in AD and supports biometal metabolism as a therapeutic target.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080049     DOI: 10.1016/j.freeradbiomed.2011.10.446

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  40 in total

1.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

2.  Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Authors:  Rosanna Squitti; Mariacarla Ventriglia; Massimo Gennarelli; Nicola A Colabufo; Imane Ghafir El Idrissi; Serena Bucossi; Stefania Mariani; Mauro Rongioletti; Orazio Zanetti; Chiara Congiu; Paolo M Rossini; Cristian Bonvicini
Journal:  Mol Neurobiol       Date:  2016-01-12       Impact factor: 5.590

Review 3.  Amyloid β Protein and Alzheimer's Disease: When Computer Simulations Complement Experimental Studies.

Authors:  Jessica Nasica-Labouze; Phuong H Nguyen; Fabio Sterpone; Olivia Berthoumieu; Nicolae-Viorel Buchete; Sébastien Coté; Alfonso De Simone; Andrew J Doig; Peter Faller; Angel Garcia; Alessandro Laio; Mai Suan Li; Simone Melchionna; Normand Mousseau; Yuguang Mu; Anant Paravastu; Samuela Pasquali; David J Rosenman; Birgit Strodel; Bogdan Tarus; John H Viles; Tong Zhang; Chunyu Wang; Philippe Derreumaux
Journal:  Chem Rev       Date:  2015-03-19       Impact factor: 60.622

4.  Zinc and Copper Differentially Modulate Amyloid Precursor Protein Processing by γ-Secretase and Amyloid-β Peptide Production.

Authors:  Hermeto Gerber; Fang Wu; Mitko Dimitrov; Guillermo M Garcia Osuna; Patrick C Fraering
Journal:  J Biol Chem       Date:  2017-01-17       Impact factor: 5.157

5.  Subcellular compartmentalisation of copper, iron, manganese, and zinc in the Parkinson's disease brain.

Authors:  Sian Genoud; Blaine R Roberts; Adam P Gunn; Glenda M Halliday; Simon J G Lewis; Helen J Ball; Dominic J Hare; Kay L Double
Journal:  Metallomics       Date:  2017-10-18       Impact factor: 4.526

Review 6.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

7.  Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.

Authors:  Itender Singh; Abhay P Sagare; Mireia Coma; David Perlmutter; Robert Gelein; Robert D Bell; Richard J Deane; Elaine Zhong; Margaret Parisi; Joseph Ciszewski; R Tristan Kasper; Rashid Deane
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

8.  Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein.

Authors:  Courtney J McCann; Samuel Jayakanthan; Mariacristina Siotto; Nan Yang; Maria Osipova; Rosanna Squitti; Svetlana Lutsenko
Journal:  Metallomics       Date:  2019-06-19       Impact factor: 4.526

9.  Inhibition of human high-affinity copper importer Ctr1 orthologous in the nervous system of Drosophila ameliorates Aβ42-induced Alzheimer's disease-like symptoms.

Authors:  Minglin Lang; Qiangwang Fan; Lei Wang; Yajun Zheng; Guiran Xiao; Xiaoxi Wang; Wei Wang; Yi Zhong; Bing Zhou
Journal:  Neurobiol Aging       Date:  2013-07-02       Impact factor: 4.673

10.  ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease.

Authors:  Rosanna Squitti; Renato Polimanti; Mariacristina Siotto; Serena Bucossi; Mariacarla Ventriglia; Stefania Mariani; Fabrizio Vernieri; Federica Scrascia; Laura Trotta; Paolo Maria Rossini
Journal:  Neuromolecular Med       Date:  2013-06-13       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.